EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors

Lu Liu, Jiayun Yu, Yang Liu, Liang Xie, Fan Hu, Hanmin Liu

Frontiers in Cell and Developmental Biology · 15.05.2025 · 13

DOI: 10.3389/fcell.2025.1572909 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 15.05.2025. Verfasst von Lu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 248 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia is a hallmark of the tumor microenvironment (TME), and it plays a crucial role in the occurrence and progression in vascular tumors. Under hypoxic conditions, hypoxia-inducible factor 1-alpha (HIF-1α) is stabilized, inducing changes in the expression of various target genes involved in angiogenesis, metabolism, and cell survival. This includes the upregulation of pro-angiogenic factors like VEGF, which promotes the formation of dysfunctional blood vessels, contributing to the worsening of the hypoxic microenvironment. At the same time, hypoxia induces a metabolic shift toward glycolysis, even in the presence of oxygen, supporting tumor cell survival and proliferation by providing necessary energy and biosynthetic precursors. This review discusses the molecular mechanisms by which hypoxia regulates angiogenesis and metabolic reprogramming in vascular tumors, highlighting the intricate link between these processes, and explores potential therapeutic strategies to target these pathways in order to develop effective treatment strategies for patients.

Schlagwörter

Stichwörter der Autor:innen

HIF-1αangiogenesishypoxiametabolic reprogrammingtumor microenvironmentvascular tumors

Autor:innen und Institutionen

  • Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Key Laboratory of Birth Defect and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.
  • NHC Key Laboratory of Chronobiology (Sichuan University), Chengdu, China.
  • The Joint Laboratory for Lung Development and Related Diseases of West China Second University Hospital, Sichuan University and School of Life Sciences of Fudan University, West China Institute of Women and Children's H…
  • Sichuan Birth Defects Clinical Research Center, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Department of Radiotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, Sichuan University, Chengdu, China.

Zitieren

APA

Liu, L., Yu, J., Liu, Y., Xie, L., Hu, F., & Liu, H. (2025). Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1572909

Vancouver

Liu L, Yu J, Liu Y, Xie L, Hu F, Liu H. Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1572909

BibTeX
@article{Liu2025,
  author = {Liu, Lu and Yu, Jiayun and Liu, Yang and Xie, Liang and Hu, Fan and Liu, Hanmin},
  title = {Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1572909}
}
Kostenlos starten →